Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 31:7:41674.
doi: 10.1038/srep41674.

Predictive radiogenomics modeling of EGFR mutation status in lung cancer

Affiliations

Predictive radiogenomics modeling of EGFR mutation status in lung cancer

Olivier Gevaert et al. Sci Rep. .

Abstract

Molecular analysis of the mutation status for EGFR and KRAS are now routine in the management of non-small cell lung cancer. Radiogenomics, the linking of medical images with the genomic properties of human tumors, provides exciting opportunities for non-invasive diagnostics and prognostics. We investigated whether EGFR and KRAS mutation status can be predicted using imaging data. To accomplish this, we studied 186 cases of NSCLC with preoperative thin-slice CT scans. A thoracic radiologist annotated 89 semantic image features of each patient's tumor. Next, we built a decision tree to predict the presence of EGFR and KRAS mutations. We found a statistically significant model for predicting EGFR but not for KRAS mutations. The test set area under the ROC curve for predicting EGFR mutation status was 0.89. The final decision tree used four variables: emphysema, airway abnormality, the percentage of ground glass component and the type of tumor margin. The presence of either of the first two features predicts a wild type status for EGFR while the presence of any ground glass component indicates EGFR mutations. These results show the potential of quantitative imaging to predict molecular properties in a non-invasive manner, as CT imaging is more readily available than biopsies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Figure 1
Figure 1. Demonstration of some of the semantic features applied to tumors in our cohort.
Note some features (e.g. airway abnormalities, emphysema) are not always depicted on the cross-sections showing the tumor. (A) Solid, lobulated squamous cell carcinoma with emphysema, (B) part solid, smooth adenocarcinoma, (C) ground glass poorly defined adenocarcinoma with airway abnormality, (D) part solid, lobulated adenocarcinoma, (E) part solid, poorly defined adenocarcinoma, (F) part solid, poorly defined adenocarcinoma.
Figure 2
Figure 2. ROC curve showing sensitivity/specificity tradeoff for predicting EGFR mutation status using 5 semantic features.
Figure 3
Figure 3. Decision tree for predicting EGFR mutation status using a combination of five semantic image features.

References

    1. Chen Z., Fillmore C. M., Hammerman P. S., Kim C. F. & Wong K. K.. Non-small-cell lung cancers: a heterogeneous set of diseases. Nature reviews. Cancer 14, 535–546 (2014). - PMC - PubMed
    1. Ellison G. et al.. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. Journal of clinical pathology 66, 79–89 (2013). - PMC - PubMed
    1. Siegelin M. D. & Borczuk A. C.. Epidermal growth factor receptor mutations in lung adenocarcinoma. Lab6oratory investigation; a journal of technical methods and pathology 94, 129–137 (2014). - PubMed
    1. Riely G. J., Marks J. & Pao W.. KRAS mutations in non-small cell lung cancer. Proceedings of the American Thoracic Society 6, 201–205 (2009). - PubMed
    1. Kwak E. L. et al.. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. The New England journal of medicine 363, 1693–1703 (2010). - PMC - PubMed

Publication types